Scott Myers

Viridian Appoints Scott Myers as President and Chief Executive Officer

Retrieved on: 
Monday, February 6, 2023

Mr. Myers has more than 30 years of biopharmaceutical and medical technology experience, and has held global executive leadership and director roles at numerous commercial- and development-stage biopharmaceutical companies.

Key Points: 
  • Mr. Myers has more than 30 years of biopharmaceutical and medical technology experience, and has held global executive leadership and director roles at numerous commercial- and development-stage biopharmaceutical companies.
  • “Scott brings to Viridian extensive late-stage clinical development, global commercial, and executive leadership experience with a proven track record of creating value.
  • His appointment puts Viridian in a position to build upon the Company’s strong foundation to achieve our shared vision of becoming a fully-integrated biopharmaceutical company.
  • Viridian also announced the grant of an inducement award to Mr. Myers as an inducement material to Mr. Myers’ employment pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules.

Scott Myers Appointed to Dynavax Board of Directors and Elected Board Chairman

Retrieved on: 
Thursday, October 21, 2021

EMERYVILLE, Calif., Oct. 21, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX),a biopharmaceutical company focused ondeveloping andcommercializing novel vaccines,today announced the appointment of Scott Myers to its Board of Directors.

Key Points: 
  • EMERYVILLE, Calif., Oct. 21, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX),a biopharmaceutical company focused ondeveloping andcommercializing novel vaccines,today announced the appointment of Scott Myers to its Board of Directors.
  • Mr. Myers was also elected Board Chairman, succeeding Dr. Andrew Hack who has served as interim Chairman of the Board since May 2020.
  • "I am thrilled to join Dynavax's Board of Directors at this exciting time in the company's growth," commented Scott Myers.
  • Mr. Myers is an independent director on the board of directors of Selecta Biosciences, Trillium Therapeutics, Inc. and Harpoon Therapeutics, Inc. Mr. Myers holds a B.A.